Using Illumina HiSeq expression data of 791 PAM50-defined breast cancer cases and 113 normal breast tissues available at TCGA portal [32], we verified a highly significant loss of DKK3 mRNA expression in all clinically relevant breast cancer subtypes compared with normal breast tissues (for all P < 0.001). The gene discussed is DKK3; the disease is breast cancer.